title: [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
abstract: Intravenous immunoglobulins (IVIG) have been used mainly as a supplement therapy in hypogammglobulinemia patients. IVIG have been proved effective in treating TTP and recently they have been used in treating many autoimmune and inflammatory diseases. In neurologic diseases IVIG have immunomodulating features dependent on IgG Fc-fragment. Which diseases benefit from the use of IVIG was the find from controlled clinical trials in accordance with Evidence Based Medicine. IVIG have been proved effective in Guillaine-Barre syndrom, chronic inflammatory demyelinating polyradiculoneuropathy, miastenia, dermathomyositis and sclerosis multiple. The recommendations include the frequency of IVIG administering its dosage and duration of treatment.
authors.affiliation: Wojskowy Instytut Medyczny w Warszawie, Zakład Transfuzjologii Klinicznej CSK MON.
authors.forename: Jolanta
authors.initials: J
authors.lastname: Korsak
mesh_terms: D020274:Autoimmune Diseases of the Nervous System / Q000188:drug therapy*; D004334:Drug Administration Schedule; D020275:Guillain-Barre Syndrome / Q000188:drug therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors